Skip to main content
Medical information Clinical review pending

Infection Testing

Aldehyde Chopra Test for Kala Azar Test

The Aldehyde Chopra Test for Kala Azar detects Leishmania parasites, aiding in the diagnosis of Kala Azar, a serious infectious disease. Essential for individuals with symptoms like prolonged fever, weight loss, and splenomegaly.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Serum
Results
Results are generally available within one day. Confirm with the laboratory before booking.
Preparation
No specific fasting is required for this test. Please inform the laboratory if you are currently taking any medications.
Test priceKSh 585

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Aldehyde Chopra Test for Kala Azar Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals presenting with symptoms suggestive of Kala Azar (e.g., prolonged fever, weight loss, enlarged spleen or liver).
  • ✓Individuals with a history of travel to or residence in areas where Kala Azar is endemic.
  • ✓Patients with unexplained fever of unknown origin, particularly in endemic regions.
  • ✓Individuals with weakened immune systems suspected of having Kala Azar.
  • ✓Monitoring treatment response in diagnosed Kala Azar patients (consult your doctor).
02

In plain language

What this test helps you understand

This test is used to detect the presence of Leishmania parasites, the causative agent of Kala Azar (Visceral Leishmaniasis). Early detection is crucial for effective treatment and preventing severe complications associated with this infectious disease.
The Aldehyde Chopra Test for Kala Azar is a specialized diagnostic test designed to detect the presence of Leishmania parasites, which are responsible for the infectious disease known as Kala Azar. This test is critical for early diagnosis and management of the disease, which can lead to severe health complications if left untreated.

This test measures the levels of specific antibodies in the serum that indicate an infection by the Leishmania species. A positive result suggests the presence of Kala Azar, allowing for prompt medical intervention.

Individuals who may need this test include:

* Those exhibiting symptoms such as prolonged fever, weight loss, and splenomegaly. * People who have traveled to endemic areas where Kala Azar is prevalent. * Individuals with weakened immune systems or those at higher risk for infections.

Taking the Aldehyde Chopra Test for Kala Azar offers several benefits:

* Early detection of Kala Azar, which is crucial for effective treatment. * Helps in monitoring the progression of the disease and response to treatment. * Facilitates better management of symptoms and overall health outcomes.

Results from the Aldehyde Chopra Test are generally available within a day. A positive result indicates an active infection, while a negative result suggests the absence of the disease. It is essential to consult a healthcare provider for interpretation of results and further management.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific fasting is required for this test. Please inform the laboratory if you are currently taking any medications.
SampleSerum
MethodologyThis test typically involves serological methods to detect antibodies against Leishmania antigens. The specific methodology may vary. Confirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects antibodies, which may take time to develop after infection. A negative result does not completely rule out Kala Azar, especially early in the infection. False positives can occur. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Kala Azar, also known as Visceral Leishmaniasis, is a serious infectious disease caused by Leishmania parasites, transmitted by sandflies. It affects internal organs like the spleen, liver, and bone marrow.
Testing is recommended for individuals with symptoms like prolonged fever, weight loss, and enlarged spleen or liver, especially those who have been in areas where the disease is common.
The test is a useful diagnostic tool, but like all tests, it has limitations. Accuracy can depend on the stage of infection and individual factors. Discuss the results with your doctor.
A positive result suggests the presence of antibodies indicating a possible Kala Azar infection. Further evaluation and consultation with a healthcare provider are necessary.
Yes, home sample collection services are available for your convenience. Please contact us to arrange.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp